Perioperative Administration of Emend ® (Aprepitant) at a Tertiary Care Children's Hospital: A 12-Month Survey.
Conclusion: Aprepitant was easily added to the preoperative regimen for pediatric patients who may require it. Our approach limited overuse and subsequent cost concerns. Future studies with a comparator group and a greater sample size are needed to demonstrate its efficacy, especially in comparison to time-honored agents such as ondansetron. No adverse effects were noted in our limited study cohort.
PMID: 31819673 [PubMed]
Source: Clinical Pharmacology: Advances and Applications - Category: Allergy & Immunology Tags: Clin Pharmacol Source Type: research
More News: Allergy & Immunology | Anesthesia | Anesthesiology | Brain | Children | Drugs & Pharmacology | Neurology | Pediatrics | Study | Zofran